Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Europe Pharmaceutical Market Variables, Trends, & Scope
3.1. Parent Market Outlook
3.2. Ancillary Market Outlook
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.3.3. Porter’s Analysis
3.3.3.1. Bargaining power of the suppliers
3.3.3.2. Bargaining power of the buyers
3.3.3.3. Threats of substitution
3.3.3.4. Threats from new entrants
3.3.3.5. Competitive rivalry
3.3.4. PESTEL Analysis
3.3.4.1. Political landscape
3.3.4.2. Economic and Social landscape
3.3.4.3. Technological landscape
3.3.4.4. Environmental landscape
3.3.4.5. Legal landscape
Chapter 4. Pharmaceutical Market: By Molecule Estimates & Trend Analysis
4.1. Pharmaceutical Market: Molecule Segment Dashboard
4.2. Pharmaceutical Market: By Molecule Movement Analysis, 2024 & 2030 (USD Million)
4.3. Biologics & Biosimilars (Large Molecules)
4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Monoclonal Antibodies
4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Vaccines
4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Cell & Gene Therapy
4.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. Others
4.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Conventional Drugs (Small Molecules)
4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Europe Pharmaceutical Market: Product Estimates & Trend Analysis
5.1. Europe Pharmaceutical Market: Product Segment Dashboard
5.2. Europe Pharmaceutical Market: By Product Movement Analysis, 2024 & 2030 (USD Million)
5.3. Branded
5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Generics
5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Europe Pharmaceutical Market: Type Estimates & Trend Analysis
6.1. Europe Pharmaceutical Market: Type Segment Dashboard
6.2. Europe Pharmaceutical Market: By Type Movement Analysis, 2024 & 2030 (USD Million)
6.3. Prescription
6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. OTC
6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Pharmaceutical Market: Disease Estimates & Trend Analysis
7.1. Pharmaceutical Market: Disease Segment Dashboard
7.2. Pharmaceutical Market: By Disease Movement Analysis, 2024 & 2030 (USD Million)
7.3. Cardiovascular diseases
7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Cancer
7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Diabetes
7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Infectious diseases
7.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Neurological disorders
7.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Respiratory diseases
7.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9. Autoimmune diseases
7.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10. Mental health disorders
7.10.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.11. Gastrointestinal disorders
7.11.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.12. Women’s Health Diseases
7.12.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.13. Genetic and Rare genetic diseases
7.13.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.14. Dermatological conditions
7.14.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.15. Obesity
7.15.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.16. Renal diseases
7.16.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.17. Liver conditions
7.17.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.18. Hematological disorders
7.18.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.19. Eye conditions
7.19.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.20. Infertility conditions
7.20.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.21. Endocrine disorders
7.21.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.22. Allergies
7.22.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.23. Others
7.23.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Pharmaceutical Market: Route of Administration Estimates & Trend Analysis
8.1. Pharmaceutical Market: Route of Administration Segment Dashboard
8.2. Pharmaceutical Market: By Route of Administration Movement Analysis, 2024 & 2030 (USD Million)
8.3. Oral
8.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. Tablets
8.3.3. Capsules
8.3.4. Suspensions
8.3.5. Other
8.4. Topical
8.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Parenteral
8.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Intravenous
8.5.3. Intramuscular
8.6. Inhalations
8.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Other Routes of Administration
8.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Pharmaceutical Market: Age Group Estimates & Trend Analysis
9.1. Pharmaceutical Market: Age Group Segment Dashboard
9.2. Pharmaceutical Market: By Age Group Movement Analysis, 2024 & 2030 (USD Million)
9.3. Children & Adolescents
9.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Adults
9.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Geriatric
9.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Pharmaceutical Market: Distribution Channel Estimates & Trend Analysis
10.1. Pharmaceutical Market: Distribution Channel Segment Dashboard
10.2. Pharmaceutical Market: By Distribution Channel Movement Analysis, 2024 & 2030 (USD Million)
10.3. Hospital Pharmacy
10.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
10.4. Retail Pharmacy
10.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
10.5. Others
10.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 11. Europe Pharmaceutical Market: Regional Estimates & Trend Analysis
11.1. Europe Pharmaceutical Market Share, By Region, 2024 & 2030 (USD Million)
11.1.1. Europe Pharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
11.1.2. UK
11.1.2.1. Key Country Dynamics
11.1.2.2. Target Disease Prevalence
11.1.2.3. Regulatory Framework
11.1.2.4. Reimbursement Framework
11.1.2.5. UK Europe Pharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
11.1.3. Germany
11.1.3.1. Key Country Dynamics
11.1.3.2. Target Disease Prevalence
11.1.3.3. Regulatory Framework
11.1.3.4. Reimbursement Framework
11.1.3.5. Germany Europe Pharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
11.1.4. France
11.1.4.1. Key Country Dynamics
11.1.4.2. Target Disease Prevalence
11.1.4.3. Regulatory Framework
11.1.4.4. Reimbursement Framework
11.1.4.5. France Europe Pharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
11.1.5. Italy
11.1.5.1. Key Country Dynamics
11.1.5.2. Target Disease Prevalence
11.1.5.3. Regulatory Framework
11.1.5.4. Reimbursement Framework
11.1.5.5. Italy Europe Pharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
11.1.6. Spain
11.1.6.1. Key Country Dynamics
11.1.6.2. Target Disease Prevalence
11.1.6.3. Regulatory Framework
11.1.6.4. Reimbursement Framework
11.1.6.5. Spain Europe Pharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
11.1.7. Denmark
11.1.7.1. Key Country Dynamics
11.1.7.2. Target Disease Prevalence
11.1.7.3. Regulatory Framework
11.1.7.4. Reimbursement Framework
11.1.7.5. Denmark Europe Pharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
11.1.8. Sweden
11.1.8.1. Key Country Dynamics
11.1.8.2. Target Disease Prevalence
11.1.8.3. Regulatory Framework
11.1.8.4. Reimbursement Framework
11.1.8.5. Finland Europe Pharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
11.1.9. Norway
11.1.9.1. Key Country Dynamics
11.1.9.2. Target Disease Prevalence
11.1.9.3. Regulatory Framework
11.1.9.4. Reimbursement Framework
11.1.9.5. Norway Europe Pharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
11.2. Rest of Europe
11.2.1. Key Country Dynamics
11.2.2. Target Disease Prevalence
11.2.3. Regulatory Framework
11.2.4. Reimbursement Framework
11.2.5. Rest of Europe Pharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 12. Competitive Landscape
12.1. Recent Developments & Impact Analysis by Key Market Participants
12.2. Company Categorization
12.3. Participant Overview
12.4. Financial Performance
12.5. Product Bench Marking
12.6. Company Market Share Analysis, 2024
12.7. Company Profiles
12.7.1. F. Hoffmann-La Roche Ltd
12.7.1.1. Participant’s Overview
12.7.1.2. Financial Performance
12.7.1.3. Product Benchmarking
12.7.1.4. Recent Developments/ Strategic Initiatives
12.7.2. Bristol-Myers Squibb Company
12.7.2.1. Participant’s Overview
12.7.2.2. Financial Performance
12.7.2.3. Product Benchmarking
12.7.2.4. Recent Developments/ Strategic Initiatives
12.7.3. AstraZeneca
12.7.3.1. Participant’s Overview
12.7.3.2. Financial Performance
12.7.3.3. Product Benchmarking
12.7.3.4. Recent Developments/ Strategic Initiatives
12.7.4. Novartis AG
12.7.4.1. Participant’s Overview
12.7.4.2. Financial Performance
12.7.4.3. Product Benchmarking
12.7.4.4. Recent Developments/ Strategic Initiatives
12.7.5. Johnson & Johnson Services, Inc.
12.7.5.1. Participant’s Overview
12.7.5.2. Financial Performance
12.7.5.3. Product Benchmarking
12.7.5.4. Recent Developments/ Strategic Initiatives
12.7.6. Gilead Sciences
12.7.6.1. Participant’s Overview
12.7.6.2. Financial Performance
12.7.6.3. Product Benchmarking
12.7.6.4. Recent Developments/ Strategic Initiatives
12.7.7. GlaxoSmithKline plc.
12.7.7.1. Participant’s Overview
12.7.7.2. Financial Performance
12.7.7.3. Product Benchmarking
12.7.7.4. Recent Developments/ Strategic Initiatives
12.7.8. Merck & Co., Inc.
12.7.8.1. Participant’s Overview
12.7.8.2. Financial Performance
12.7.8.3. Product Benchmarking
12.7.8.4. Recent Developments/ Strategic Initiatives
12.7.9. Pfizer Inc.
12.7.9.1. Participant’s Overview
12.7.9.2. Financial Performance
12.7.9.3. Product Benchmarking
12.7.9.4. Recent Developments/ Strategic Initiatives
12.7.10. Sanofi
12.7.10.1. Participant’s Overview
12.7.10.2. Financial Performance
12.7.10.3. Product Benchmarking
12.7.10.4. Recent Developments/ Strategic Initiatives
12.7.11. GlaxoSmithKline plc.
12.7.11.1. Participant’s Overview
12.7.11.2. Financial Performance
12.7.11.3. Product Benchmarking
12.7.11.4. Recent Developments/ Strategic Initiatives
12.7.12. Boehringer Ingelheim GmbH
12.7.12.1. Participant’s Overview
12.7.12.2. Financial Performance
12.7.12.3. Product Benchmarking
12.7.12.4. Recent Developments/ Strategic Initiatives
Chapter 13. Key Recommendations
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Europe Pharmaceutical Market, By Country, 2018 - 2030 (USD Billion)
Table 4. Europe Pharmaceutical Market, By Molecule, 2018 - 2030 (USD Billion)
Table 5. Europe Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 6. Europe Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 7. Europe Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 8. Europe Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 9. Europe Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 10. Europe Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 11. Germany Pharmaceutical Market, By Molecule, 2018 - 2030 (USD Billion)
Table 12. Germany Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 13. Germany Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 14. Germany Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 15. Germany Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 16. Germany Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 17. Germany Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 18. UK Pharmaceutical Market, By Molecule, 2018 - 2030 (USD Billion)
Table 19. UK Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 20. UK Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 21. UK Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 22. UK Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 23. UK Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 24. UK Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 25. France Pharmaceutical Market, By Molecule, 2018 - 2030 (USD Billion)
Table 26. France Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 27. France Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 28. France Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 29. France Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 30. France Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 31. France Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 32. Italy Pharmaceutical Market, By Molecule, 2018 - 2030 (USD Billion)
Table 33. Italy Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 34. Italy Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 35. Italy Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 36. Italy Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 37. Italy Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 38. Italy Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 39. Spain Pharmaceutical Market, By Molecule, 2018 - 2030 (USD Billion)
Table 40. Spain Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 41. Spain Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 42. Spain Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 43. Spain Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 44. Spain Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 45. Spain Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 46. Denmark Pharmaceutical Market, By Molecule, 2018 - 2030 (USD Billion)
Table 47. Denmark Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 48. Denmark Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 49. Denmark Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 50. Denmark Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 51. Denmark Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 52. Denmark Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 53. Sweden Pharmaceutical Market, By Molecule, 2018 - 2030 (USD Billion)
Table 54. Sweden Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 55. Sweden Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 56. Sweden Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 57. Sweden Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 58. Sweden Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 59. Sweden Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Billion)
Table 60. Norway Pharmaceutical Market, By Molecule, 2018 - 2030 (USD Billion)
Table 61. Norway Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 62. Norway Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 63. Norway Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 64. Norway Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 65. Norway Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 66. Norway Pharmaceutical Market, By Distribution Channel, 2018 - 2030 (USD Billion)
List of Figures
Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Europe Pharmaceutical Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Europe Pharmaceutical market: Molecule outlook and key takeaways
Fig. 15 Europe Pharmaceutical market: Molecule movement analysis & market share 2024 & 2030
Fig. 16 Biologics & biosimilars (large molecules) market, 2018 - 2030 (USD Billion)
Fig. 17 Monoclonal Antibodies market, 2018 - 2030 (USD Billion)
Fig. 18 Vaccines market, 2018 - 2030 (USD Billion)
Fig. 19 Cell & Gene Therapy market, 2018 - 2030 (USD Billion)
Fig. 20 Others market, 2018 - 2030 (USD Billion)
Fig. 21 Conventional drugs (small molecules) market, 2018 - 2030 (USD Billion)
Fig. 22 Europe Pharmaceutical market: Product outlook and key takeaways
Fig. 23 Europe Pharmaceutical market: Product movement analysis & market share 2024 & 2030
Fig. 24 Branded pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 25 Generics pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 26 Pharmaceutical market: Type outlook and key takeaways
Fig. 27 Pharmaceutical market: Type movement analysis & market share 2024 & 2030
Fig. 28 Prescription pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 29 OTC pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 30 Europe Pharmaceutical market: Disease outlook and key takeaways
Fig. 31 Europe Pharmaceutical market: Disease movement analysis & market share 2024 & 2030
Fig. 32 Cancer market, 2018 - 2030 (USD Billion)
Fig. 33 Cardiovascular diseases market, 2018 - 2030 (USD Billion)
Fig. 34 Diabetes market, 2018 - 2030 (USD Billion)
Fig. 35 Infectious diseases market, 2018 - 2030 (USD Billion)
Fig. 36 Neurological disorders market, 2018 - 2030 (USD Billion)
Fig. 37 Respiratory diseases market, 2018 - 2030 (USD Billion)
Fig. 38 Autoimmune diseases market, 2018 - 2030 (USD Billion)
Fig. 39 Mental health disorders market, 2018 - 2030 (USD Billion)
Fig. 40 Gastrointestinal diseases market, 2018 - 2030 (USD Billion)
Fig. 41 Women’s health diseases market, 2018 - 2030 (USD Billion)
Fig. 42 Genetic and rare genetic diseases market, 2018 - 2030 (USD Billion)
Fig. 43 Dermatological conditions market, 2018 - 2030 (USD Billion)
Fig. 44 Obesity market, 2018 - 2030 (USD Billion)
Fig. 45 Renal diseases market, 2018 - 2030 (USD Billion)
Fig. 46 Liver conditions market, 2018 - 2030 (USD Billion)
Fig. 47 Hemotological disorders market, 2018 - 2030 (USD Billion)
Fig. 48 Eye conditions market, 2018 - 2030 (USD Billion)
Fig. 49 Infertility conditions market, 2018 - 2030 (USD Billion)
Fig. 50 Endocrine disorders market, 2018 - 2030 (USD Billion)
Fig. 51 Allergies market, 2018 - 2030 (USD Billion)
Fig. 52 Other diseases market, 2018-2030 (USD Billion)
Fig. 53 Europe Pharmaceutical market: Route of administration outlook and key takeaways
Fig. 54 Europe Pharmaceutical market: Route of administration movement analysis & market share 2024 & 2030
Fig. 55 Oral pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 56 Tablets pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 57 Capsules pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 58 Suspensions pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 59 Others formulation pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 60 Topical pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 61 Parenteral pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 62 Intravenous market, 2018 - 2030 (USD Billion)
Fig. 63 Intramuscular market, 2018 - 2030 (USD Billion)
Fig. 64 Inhalations pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 65 Others pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 66 Pharmaceutical market: Age group outlook and key takeaways
Fig. 67 Pharmaceutical market: Age group movement analysis & market share 2024 & 2030
Fig. 68 Children & Adolescents pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 69 Adults pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 70 Geriatric pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 71 Europe Pharmaceutical market: Distribution Channel outlook and key takeaways
Fig. 72 Europe Pharmaceutical market: Distribution Channel movement analysis & market share 2024 & 2030
Fig. 73 Hospital Pharmacy pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 74 Retail Pharmacy pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 75 Others pharmaceutical market, 2018 - 2030 (USD Billion)
Fig. 76 Regional Outlook, 2024 & 2030
Fig. 77 Regional Market Dashboard
Fig. 78 Regional Market Place: Key Takeaways
Fig. 79 Europe
Fig. 80 Europe Market Estimates And Forecast, 2018 - 2030 (USD Billion)
Fig. 81 UK Key Country Dynamics
Fig. 82 UK Market Estimates And Forecast, 2018 - 2030 (USD Billion)
Fig. 83 Germany Key Country Dynamics
Fig. 84 Germany Market Estimates And Forecast, 2018 - 2030 (USD Billion)
Fig. 85 France Key Country Dynamics
Fig. 86 France Market Estimates And Forecast, 2018 - 2030 (USD Billion)
Fig. 87 Italy Key Country Dynamics
Fig. 88 Italy Market Estimates And Forecast, 2018 - 2030 (USD Billion)
Fig. 89 Spain Key Country Dynamics
Fig. 90 Spain Market Estimates And Forecast, 2018 - 2030 (USD Billion)
Fig. 91 Denmark Key Country Dynamics
Fig. 92 Denmark Market Estimates And Forecast, 2018 - 2030 (USD Billion)
Fig. 93 Sweden Key Country Dynamics
Fig. 94 Sweden Market Estimates And Forecast, 2018 - 2030 (USD Billion)
Fig. 95 Norway Key Country Dynamics
Fig. 96 Norway Market Estimates And Forecast, 2018 - 2030 (USD Billion)
Fig. 97 Rest of Europe Key Country Dynamics
Fig. 98 Rest of Europe Market Estimates And Forecast, 2018 - 2030 (USD Billion)